Here’s What Wall Street Thinks About Humana Inc (HUM)

​Recently, connected January 27, David S Macdonald from Truist Financial reiterated a Hold standing connected the banal without disclosing immoderate terms targets. On the aforesaid day, Lance Wilkes from Bernstein reiterated a Buy standing connected Humana Inc. (NYSE:HUM) with a $344 terms target.

​On January 27, Piper Sandler released a probe enactment discussing the interaction of Medicare Advantage Advance Notice connected healthcare stocks. Medicare Advantage is simply a backstage security alternate to accepted Medicare, which covers astir fractional of the US seniors. The latest announcement sets a benchmark for insurers specified arsenic Humana Inc, which is expected to straight interaction gross and nett margins.

​Moreover, connected the aforesaid day, Reuters reported that the Trump medication has projected a overmuch smaller than expected summation successful 2027 Medicare Advantage rates. Since the news, the stock terms of Humana Inc. (NYSE:HUM) has fallen much than 24%, bringing it adjacent to its 52-week lows.

​Humana Inc. (NYSE:HUM) is simply a starring wellness security and well-being institution focused connected Medicare Advantage plans, Medicaid services, and specialty security products for individuals and leader groups.

While we admit the imaginable of HUM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.